Proxy Materials

SELLAS Life Sciences Group, Inc. Filed 2016-06-09 Acc 0001390478-16-000113

Documents 1

2016-07-08 DEFA14A Proxy Materials
2016-06-09 DEFA14A Proxy Materials
2016-06-07 4 Former Chief Financial Officer sold 126,875 shares at $2.18 ($276,588)
2016-06-06 NO ACT No Action Letter
2016-06-03 DEFA14A Proxy Materials
2016-06-03 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading gale-20160609xformdefaaddi.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…